SIX-MONTH REPORT JANUARY –JUNE 2014 April–June Net

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SIX-MONTH REPORT JANUARY –JUNE 2014

April–June · Net sales rose by about 15% to SEK 2,530k (2,200k). · Loss after financial items was SEK 4,803k (loss: 3,903k). · Comprehensive income was a loss of SEK 4,803k (loss: 3,852k). · Comprehensive income per share basic and diluted totaled SEK -0.22 (-0.27). · Cash flow from operating activities during the period was SEK -5,767k ( -3,251k). · Cash and cash equivalents including short-term investments amounted to SEK 16,829k (10,851k) at the end of the period. · The company launched a new product format that will make validation of FabRICATOR®easier for customers. January - June · Net sales rose by about 10% to SEK 4,514k (4,106k). · Loss after financial items was SEK 8,642k (loss: 7,860k). · Comprehensive income was a loss of SEK 8,642k (loss: 7,799k). · Comprehensive income per share basic and diluted totaled SEK -0.41 (-0.60). · Cash flow from operating activities during the six-month period was SEK -11,980k (-7,680k). Comments from CEO Sarah Fredriksson During the second quarter, sales increased by about 15 percent year on year, and by 28 percent quarter on quarter. Sales in North America jumped 25 percent in the second quarter compared with the second quarter of 2013. Overall this performance represents positive confirmation that our customer base continues to grow, as does demand for our enzyme products. To take full advantage of the potential of our products, our efforts are aimed at convincing the market to implement a shift in technology. We would like to see our customers begin using our first product, FabRICATOR®, in quality control for commercial production of antibody-based drugs. As part of this strategy the Company launched a new product during the second quarter that will facilitate validation of our product.  We also have a special focus on the US market, where we are transitioning from distribution to direct sales. This process, which is on schedule and is expected to be completed by year-end in both North America and Europe, has entailed an increase in expenses of about 4 percent for the parent company during the period. In the wholly-owned subsidiary GeccoDots, activities have intensified in R&D and in marketing of products for the preclinical market as well as in projects aimed at clinical development in the long term. Developments in the subsidiary have resulted in increased costs that have had a negative impact on the consolidated results.  All development projects are on track and it is both exciting and inspiring that we were recently able to present two scientific papers reporting good results from the Sentinel Node project’s preclinical studies. For more information, please contact: Sarah Fredriksson, CEO, Genovis AB Tel: 46 (0)46 -101235 sarah.fredriksson@genovis.com ABOUT GENOVIS Genovis’ business concept is to develop, produce and market innovative technologies that facilitate and enable development of new treatment methods and diagnostics for customers in the medical device and pharmaceutical industries. The Group consists of Genovis AB and the subsidiary GeccoDots AB. Genovis develops and sells unique enzymes in innovative product formats that facilitate development and quality control of and biological drugs. GeccoDots uses nanotechnology to produce a new type of contrast agent that is used in medical imaging. Genovis shares are listed on NASDAQ OMX First North, and Thenberg Fondkommission is Certified Adviser for the Company, t: 46 (0)31-745 50 00

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 44

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 44

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 61

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 38

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 56

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 46

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 48

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding the Strategic Position of Primary Health Properties

Updated Category News Views 168

Public Opening Position Disclosure and Its Importance The nature of public disclosures in the market plays a crucial role in maintaining transparency for investors, particularly regarding entities that hold significant interests in various securities. This is particularly relevant for organizations such as Primary Health Properties Plc. When a person or entity holds 1% or...

Continue Reading
BingX Achieves Prestigious ISO 27001 Certification

Updated Category News Views 158

BingX Marks a Significant Milestone with ISO 27001 Certification In today’s digital world, security is paramount, and BingX has taken a significant leap forward by achieving the esteemed ISO/IEC 27001 certification. This internationally recognized standard focuses on information security management systems (ISMS), and serves as a beacon for organizations striving to...

Continue Reading
Market Movements: U.K. Stocks Decline as Sector Weakens

Updated Category News Views 229

U.K. Stocks Experience a Decline in Trading As the trading day came to a close, U.K. stocks reflected a downward trend, primarily influenced by particular sectors such as Healthcare Equipment & Services, Fixed Line Telecommunications, and Automobiles & Parts. This subdued performance resulted in a notable decrease in the overall market indices. Key Indices Performance The...

Continue Reading
Revamped Spaces at Vilnius Akropolis Enhance Visitor Experience

Updated Category News Views 162

Transformation of Common Areas at Vilnius Akropolis The common spaces on the second floor of the shopping and entertainment centre Akropolis in Vilnius have undergone a remarkable renovation. With over 1,500 square meters freshly modernized, visitors are now welcomed into a more inviting, brighter, and comfortable environment. An investment of approximately EUR 800,000...

Continue Reading
Projected Growth of North American Copper Tubes Sector

Updated Category News Views 113

Overview of the North American Copper Tubes Market The North American Copper Tubes Market is positioned for significant growth, with projections estimating it to rise from USD 3.18 billion to USD 3.44 billion. This growth trajectory, calculated at a CAGR of 4.0% from 2024 to 2030, demonstrates increasing demand primarily driven by various sectors including construction...

Continue Reading